CHRNA7 and nervous system disorder: Although the most recognized mechanism of action for memantine is the non-competitive antagonism of the NMDA receptor (Lipton, 2006; Johnson and Kotermanski, 2006; Song et al., 2018), other publications recognize its potential to inhibit the α7 nAChR as a pharmacological target for neurological diseases (Maskell et al., 2003).